Herb Profile

Mangifera Indica

Mangifera indica

Mangifera Indica (Mangifera indica) carries a Grade C rating — limited evidence.

Last reviewed: 3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution May lower blood glucose or alter metabolic markers; monitor with diabetes medications and avoid unsupervised use during pregnancy. Details

Evidence
Limited Evidence
Typical onset
Varies by prep
Safety rating
High caution
Best for
Antioxidant, Metabolic, Stress resilience, Inflammatory signaling
Avoid / review if
Pregnancy/Breastfeeding Without Clinician Supervision, Known Allergy To The Plant/Family, Potential Interaction Concern With Antidiabetic Medicines
Mangifera Indica monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
May lower blood glucose or alter metabolic markers; monitor with diabetes medications and avoid unsupervised use during pregnancy.
Profile context
antioxidant, metabolic
Next steps

Continue reading

Safety

Safety & Cautions

May lower blood glucose or alter metabolic markers; monitor with diabetes medications and avoid unsupervised use during pregnancy.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Pregnancy/Breastfeeding Without Clinician Supervision
  • Known Allergy To The Plant/Family
  • Potential Interaction Concern With Antidiabetic Medicines
  • Immunosuppressants
  • Use Clinician Review For High Dose Extracts Or Chronic Use.

Safety classifications

  • Interaction-Aware: Medication or interaction context is explicitly noted.
  • Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

  • May lower blood glucose or alter metabolic markers; monitor with diabetes medications and avoid unsupervised use during pregnancy.

Safety labels

  • Interaction-Aware
  • Pregnancy/Breastfeeding Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mappedOxidative Stress Modulation · Metabolic Regulation · AMPK Signaling

Research maturity: Emerging researchLong Term Human Evidence May Be Limited.

Safety boundary: Safety note availableMay lower blood glucose or alter metabolic markers; monitor with diabetes medications and avoid unsupervised use during pregnancy.

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Systematic review
Risk of Bias
Low
Consistency
Not assessed
Strongest recorded design is a systematic review, drawn from 3 recorded studies, 2 in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (5)2 human evidence sources · 1 human trial · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 5 of 5 studies.

What the evidence actually shows

This table contains 5 structured sources, including 2 human evidence sources; 1 is a human trial.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

A 2023 systematic review found that human studies use very different mango matrices (fruit, leaf, isolated/standardized extracts), making cross-product generalization unreliable.

Background
Systematic review

Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically.

A 2023 systematic review found that human studies use very different mango matrices (fruit, leaf, isolated/standardized extracts), making cross-product generalization unreliable.PubMed

A 2024 randomized trial in 114 healthy adults found mixed cognitive results with a standardized mango-leaf extract; broad cognitive enhancement was not established, and at least one arithmetic-error outcome moved in an unfavorable direction.

Background
Randomized controlled trial

Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.

A 2024 randomized trial in 114 healthy adults found mixed cognitive results with a standardized mango-leaf extract; broad cognitive enhancement was not established, and at least one arithmetic-error outcome moved in an unfavorable direction.PubMed

A Review on Phytochemistry, Ethnopharmacology, and Antiparasitic Potential of Mangifera indica L

Mendonça D et al. · Pharmaceuticals (Basel) · 2025

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Mangifera indica (mango)

Shah KA et al. · Pharmacogn Rev · 2010

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Anti-inflammatory and immunomodulatory activity of Mangifera indica L. reveals the modulation of COX-2/mPGES-1 axis and Th17/Treg ratio

Saviano A et al. · Pharmacol Res · 2022

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Preparation varies by tradition and product form and require source backed dosage review before therapeutic claims.
How Mangifera Indica works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Mangifera Indica Works

How Mangifera Indica WorksMangifera Indica acts on biological target pathways via antioxidant, leading to antioxidant efct.Mangifera IndicaBiological TargetBiological pathwayAntioxidantAntioxidant EfctCell protectionMetabolicRegulation
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
  • Oxidative Stress Modulation
  • Metabolic Regulation
  • AMPK Signaling
  • NF KB Modulation
  • Nrf2 Activation

Active Compounds

Key constituents studied in Mangifera Indica, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Mangifera Indica

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Mangifera Indica

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Mangifera Indica research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.